Your browser doesn't support javascript.
Reply to the letter entitled "Suggested treatment of serious complications to Covid-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme".
Gruel, Yves; Vayne, Caroline; Rollin, Jérôme; Pouplard, Claire.
  • Gruel Y; Department of Haemostasis and EA7501 GICC, University Hospital of Tours, Tours, France.
  • Vayne C; Department of Haemostasis and EA7501 GICC, University Hospital of Tours, Tours, France.
  • Rollin J; Department of Haemostasis and EA7501 GICC, University Hospital of Tours, Tours, France.
  • Pouplard C; Department of Haemostasis and EA7501 GICC, University Hospital of Tours, Tours, France.
J Thromb Haemost ; 19(10): 2632, 2021 10.
Article in English | MEDLINE | ID: covidwho-1334501
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2021 Document Type: Article Affiliation country: Jth.15465

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2021 Document Type: Article Affiliation country: Jth.15465